MedTrace Logo

Stool Testing With Molecular Assay to Minimize Contact Precautions

NCT04189874 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2021-03-17

No results posted yet for this study

Summary

This study evaluates the impact of infectious diseases molecular-based stool testing compared to conventional stool testing on reducing the need for contact precautions among hospitalized patients. Half of patients' stools will be tested with the molecular assay , while the other half will be tested with conventional testing.

Conditions

  • Infectious Gastroenteritis

Interventions

DIAGNOSTIC_TEST

Conventional Stool Testing

Stools are tested using conventional culture techniques

DIAGNOSTIC_TEST

BioFire FilmArray Gastrointestinal Panel

Molecular-based stool assay

Sponsors & Collaborators

  • Biomerieux inc

    collaborator INDUSTRY

  • Giulio DiDiodato

    lead OTHER

Principal Investigators

  • Giulio DiDiodato, PhD · Royal Victoria Regional Health Centre

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-18
Primary Completion
2020-12-31
Completion
2021-02-12

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04189874 on ClinicalTrials.gov